Organization Overview
Historical Acquisition Tree
Alternative names
ibrutinib (imbruvica) (2013 NDA)
acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (1 trial)
allopurinol (zyloprim) (1 trial)
azacitidine (vidaza) (2 trials)
blinatumomab (blincyto) (1 trial)
carfilzomib (kyprolis) (2 trials)
cetuximab (erbitux) (2 trials)
cytarabine (cytosar-u) (3 trials)
docetaxel (taxotere) (1 trial)
Adenocarcinoma (Phase 3)
Anemia, Refractory (Phase 1)
Astrocytoma (Phase 1)
Brain Neoplasms (Phase 3)
Breast Neoplasms (Phase 2)
Burkitt Lymphoma (Phase 2)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Bronchogenic (Phase 1)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Central Nervous System Neoplasms (Phase 1)
Digestive System Neoplasms (Phase 1)
Disease Progression (Phase 1)
Gastrointestinal Neoplasms (Phase 1)
Glioblastoma (Phase 1)
Glioma (Phase 1)
Graft vs Host Disease (Phase 4)
Head and Neck Neoplasms (Phase 1)
Hematologic Neoplasms (Phase 1)
Hodgkin Disease (Phase 2)
Intestinal Neoplasms (Phase 1)
Kidney Neoplasms (Phase 2)
Laryngeal Neoplasms (Phase 1)
Leukemia (Phase 3)
Leukemia, B-Cell (Phase 4)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 1)
Leukemia, Myelomonocytic, Juvenile (Phase 1)
Leukemia, Prolymphocytic (Phase 2)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 4)
Lymphoma, B-Cell (Phase 4)
Lymphoma, B-Cell, Marginal Zone (Phase 3)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Mantle-Cell (Phase 4)
Lymphoma, Non-Hodgkin (Phase 4)
Lymphoma, T-Cell (Phase 1)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 1)
Myeloproliferative Disorders (Phase 1)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms by Site (Phase 1)
Neoplasms, Plasma Cell (Phase 2)
Neoplasms, Second Primary (Phase 2)
Nervous System Neoplasms (Phase 1)
Neuroendocrine Tumors (Phase 2)
Neurotoxicity Syndromes (Phase 1)
Oligodendroglioma (Phase 1)
Oropharyngeal Neoplasms (Phase 1)
Ovarian Neoplasms (Phase 1)
Pancreatic Neoplasms (Phase 2)
Philadelphia Chromosome (Phase 2)
Preleukemia (Phase 1)
Prostatic Neoplasms (Phase 1)
Sarcoma (Phase 2)
Smoldering Multiple Myeloma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Syndrome (Phase 2)
Urogenital Neoplasms (Phase 2)
Urologic Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 3)